Myopia Control

Myopia or shortsightedness is where the eyeball has grown too long or too powerful and has resulted in blurry vision in the distance.  Near vision is clear within a certain range depending on the level of myopia.

The prevalence of myopia is currently on the increase globally and the current research predicts that by 2050 there will be 4758 million people with myopia (49.8% of the world population; 3620–6056 million [95% CI, 43.4%–55.7%]) and 938 million people with high myopia (9.8% of the world population; 479–2104 million [95% CI, 5.7%–19.4%]).

Myopia control is the area of science dedicated to slowing down or stopping the progression, or worsening, of myopia in children and young adults.

We need to try and control myopia development and progression due to the fact that once you become myopic, it tends to worsen over time.  Higher levels of myopia are associated with higher risks of eye diseases like glaucoma, retinal detachment and cataract.

There are a number of risk factors that impact myopia development and progression such as genetics, individual characteristics and environment. The table below summarises the different types of vision correction available for myopia control and their effectiveness. At VSI we can assist with all these treatment options:

Type of Vision Correction Effect on Slowing Myopic Progression
Normal glasses and standard contact lenses 0 – 5%
Progressive/bifocal lenses 12 – 55%
Myovision (special design spectacle lenses) 0 – 30%
Orthokeratology/CRT 32 – 100%
Low dose atropine 30 – 77%

For detailed research papers on all of these options refer to the following website